Greenwich Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
SDH
EP
Greenwich Wealth Management's ARKG Position: Q2 2021 in Review
Greenwich Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 4,870 shares — an estimated $432K sold.
Greenwich Wealth Management first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $432K in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.
- Greenwich Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
- Greenwich Wealth Management sold 4,870 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $432K.
- Greenwich Wealth Management first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
- Greenwich Wealth Management's ARK Genomic Revolution ETF position peaked at $432K in Q1 2021.
- 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.
Based on Greenwich Wealth Management's 13F filing for Q2 2021, filed 27 Jul 2021.